• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Hydrolyzed infant formula may not reduce the risk of allergies or autoimmune disease

byDeepti Shroff KarhadeandDavid Wang
March 26, 2016
in Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a systematic review of 37 trials representing over 19 000 infants, the use of hydrolyzed infant formula demonstrated no significant reduction in subsequent risk of developing allergic or autoimmune diseases compared to cows’ milk.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: The prevalence of allergic and atopic conditions, such as atopic wheeze, asthma, and food allergies, have significantly increased in developed countries, affecting as much as 20% of the population in the United States. Nutritional guidelines from the United States and other developed countries have recommended the use of hydrolyzed infant formula in the first 4 to 6 months of life for the primary prevention of infant allergic diseases. However, there has been a paucity of reports analyzing the strength of evidence for these recommendations. The purpose of this systematic review was to investigate the risk of allergic or autoimmune disease in infants using hydrolyzed versus cows’ milk formula.

The study reviewed 37 eligible studies, comprised of over 19 000 infants, which compared the use of hydrolyzed versus cows’ milk formula in infants.  At the conclusion of the study, there was no significant difference in the risk of allergic or autoimmune outcomes in infants between cows’ milk and partially or extensively hydrolyzed infant formula. Additionally, many of the eligible trials demonstrated evidence of industry conflicts of interest and unclear risk of bias. There was also evidence of publication bias for studies analyzing outcomes of wheeze and eczema. The results of this study challenge current guidelines in the United States and other developed nations regarding the benefits of hydrolyzed infant formula and highlight the need for additional independently funded studies to clarify the potential beneficial effect of hydrolyzed infant formula versus cows’ milk.

Click to read the study in BMJ

Click to read an accompanying editorial in BMJ

Relevant Reading: Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants

RELATED REPORTS

Early exposure to allergenic foods may reduce incidence of long-term food allergy

Peanut oral immunotherapy desensitizes young children with non-anaphylactic peanut allergies

Preterm formula powder is not inferior to human milk fortifier as breast milk fortifier

In-Depth [systematic review and meta-analysis]: The systematic review analyzed any intervention trials that included hydrolyzed formula of cows’ milk origin compared to any non-hydrolyzed cows’ milk formula. Trials were identified by extracting data from Medline, EMBASE, Web of Sciences, CENTRA, and LILACS databases between 1946 and 2015. Key exclusion criteria included trials that included hydrolyzed formula of milk other than cows’ milk. Overall, 37 intervention trials were included, which represented over 19,000 infants. The outcome of interest were atopic and autoimmune outcomes including atopic wheeze, eczema, allergic rhinitis, food allergy, type 1 diabetes mellitus, inflammatory bowel disease, psoriasis, and juvenile rheumatoid arthritis. Selection of study and data extraction were performed by two authors of the study via consensus. Quality assessment of studies were performed using the Cochrane risk of bias tool. At the conclusion of the study, no benefits were observed in using hydrolyzed formula compared to standard cows’ milk to reduce risk of allergic or autoimmune outcomes in infants. The odds ratio for developing eczema in infants from ages 0-4 was 0.84 (95%CI: 0.67 to 1.07; I2 = 30%) for partially hydrolyzed formula, 0.55 (95%CI: 0.28 to 1.09; I2 = 74%) for extensively hydrolyzed casein based formula, and 1.12 (95%CI: 0.88 to 1.42; I2 = 0%) whey-based extensively hydrolyzed formula.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Food Allergyinfant formula
Previous Post

Periodontal disease associated with increased rate of cognitive decline in Alzheimer’s dementia

Next Post

Uterocervical angle a sensitive predictor of preterm birth

RelatedReports

Peripregnancy nut consumption may decrease development of nut allergies
Chronic Disease

Early exposure to allergenic foods may reduce incidence of long-term food allergy

July 5, 2022
Peripregnancy nut consumption may decrease development of nut allergies
Chronic Disease

Peanut oral immunotherapy desensitizes young children with non-anaphylactic peanut allergies

March 1, 2022
Early feeding practices modifiable through appropriate education
Obstetrics

Preterm formula powder is not inferior to human milk fortifier as breast milk fortifier

June 2, 2021
Health A to Z

Patient Basics: Food Allergy

November 30, 2014
Next Post
Increased risk of stillbirth recurrence after a previous stillbirth

Uterocervical angle a sensitive predictor of preterm birth

Increased complications associated with emergent repeat cesarean

Oxytocin and foley balloon linked to faster delivery in nulliparas

Live attenuated vaccine less effective in recent influenza season

Stem cell therapy could reduce influenza-associated respiratory complications [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options